Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Leticia R. Cruz, Idania Baladrón, Aliusha Rittoles, Pablo A. Díaz, Carmen Valenzuela, Raúl Santana, Maria M. Vázquez, Ariadna García, Deyli Chacón, Delvin Thompson, Gustavo Perera, Ariel González, Rafael Reyes, Loida Torres, Jesus Pérez, Dania M. Vázquez, Gilda Lemus, View ORCID ProfileMauro Rosales, Ailyn C. Ramón, George V. Perez, Gerardo Guillén, Verena Muzio, View ORCID ProfileYasser Perera, Silvio E. Perea, for the ATENEA-Co-300 group
doi: https://doi.org/10.1101/2020.09.03.20187112
Leticia R. Cruz
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Idania Baladrón
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Aliusha Rittoles
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Pablo A. Díaz
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Carmen Valenzuela
3Center for Molecular Immunology, Havana 11600, Cuba
Raúl Santana
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Maria M. Vázquez
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Ariadna García
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Deyli Chacón
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Delvin Thompson
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Gustavo Perera
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Ariel González
4International Center of Health “La Pradera”, Havana 11600, Cuba
Rafael Reyes
5National Institute of Oncology and Radiobiology, Havana 10400, Cuba
Loida Torres
4International Center of Health “La Pradera”, Havana 11600, Cuba
Jesus Pérez
1Central Hospital “Luis Diaz Soto”, Havana 19130, Cuba
Dania M. Vázquez
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Gilda Lemus
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Mauro Rosales
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
6Faculty of Biology, University of Havana, Havana 10400, Cuba
Ailyn C. Ramón
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
George V. Perez
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Gerardo Guillén
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Verena Muzio
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
Yasser Perera
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
7China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Yongzhou Zhong Gu Biotechnology Co., Ltd, Yangjiaqiao Street, Lengshuitan District, Yongzhou City, Hunan 425000, China
Silvio E. Perea
2Center for Genetic Engineering and Biotechnology, Havana 10600, Cuba
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data referred in the manuscript is available.
Posted September 15, 2020.
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Leticia R. Cruz, Idania Baladrón, Aliusha Rittoles, Pablo A. Díaz, Carmen Valenzuela, Raúl Santana, Maria M. Vázquez, Ariadna García, Deyli Chacón, Delvin Thompson, Gustavo Perera, Ariel González, Rafael Reyes, Loida Torres, Jesus Pérez, Dania M. Vázquez, Gilda Lemus, Mauro Rosales, Ailyn C. Ramón, George V. Perez, Gerardo Guillén, Verena Muzio, Yasser Perera, Silvio E. Perea, for the ATENEA-Co-300 group
medRxiv 2020.09.03.20187112; doi: https://doi.org/10.1101/2020.09.03.20187112
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Leticia R. Cruz, Idania Baladrón, Aliusha Rittoles, Pablo A. Díaz, Carmen Valenzuela, Raúl Santana, Maria M. Vázquez, Ariadna García, Deyli Chacón, Delvin Thompson, Gustavo Perera, Ariel González, Rafael Reyes, Loida Torres, Jesus Pérez, Dania M. Vázquez, Gilda Lemus, Mauro Rosales, Ailyn C. Ramón, George V. Perez, Gerardo Guillén, Verena Muzio, Yasser Perera, Silvio E. Perea, for the ATENEA-Co-300 group
medRxiv 2020.09.03.20187112; doi: https://doi.org/10.1101/2020.09.03.20187112
Subject Area
Subject Areas
- Addiction Medicine (346)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2636)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12206)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4081)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2639)
- Health Policy (1002)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3861)
- Nursing (209)
- Nutrition (575)
- Oncology (2017)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6512)
- Radiology and Imaging (1396)
- Respiratory Medicine (871)
- Rheumatology (403)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)